{
    "nodes": [
        [
            "Calcitonin Gene-Related Peptide",
            "DRUG"
        ],
        [
            "erenumab",
            "DRUG"
        ],
        [
            "Botulinum Toxins, Type A",
            "DRUG"
        ],
        [
            "rimegepant sulfate",
            "DRUG"
        ],
        [
            "Migraine",
            "DISEASE"
        ],
        [
            "Calcitonin",
            "DRUG"
        ],
        [
            "CGRP",
            "GENE"
        ],
        [
            "Topiramate",
            "DRUG"
        ],
        [
            "Pituitary Adenylate Cyclase-Activating Polypeptide",
            "DRUG"
        ],
        [
            "Substance P",
            "DRUG"
        ],
        [
            "Sumatriptan",
            "DRUG"
        ]
    ],
    "edges": [
        [
            [
                "CGRP",
                "erenumab"
            ],
            12.99851,
            [
                [
                    "Kota Oshima, Keiko Ihara, Narumi Watanabe, Ryo Takemura, Kei Ishizuchi, Nobuyuki Takahashi, Mamoru Shibata, Jin Nakahara, Tsubasa Takizawa (2025). Efficacy and Safety of Switching Between Anti-CGRP Monoclonal Antibodies: A Detailed Monthly and Long-term Follow-up Study and Literature Review. Internal medicine (Tokyo, Japan). https://doi.org/10.2169/internalmedicine.4360-24 PMID: 39756881",
                    "39756881"
                ],
                [
                    "Anna Maria Florescu, Lærke Vig Lannov, Samaira Younis, Christopher Kjaer Cullum, Basit Ali Chaudhry, Thien Phu Do, Faisal Mohammad Amin (2024). No wearing-off effect of erenumab or fremanezumab for chronic migraine prevention: a single-center, real-world, observational study. Cephalalgia : an international journal of headache, 3331024231222915. https://doi.org/10.1177/03331024231222915 PMID: 38215232",
                    "38215232"
                ],
                [
                    "Oralee J Varnado, Brenna L Brady, Anthony J Zagar, Yvonne P Robles, Margaret Hoyt (2024). Comparison of Treatment Patterns in Patients with Migraine Initiating Calcitonin Gene-Related Peptide Monoclonal Antibodies: A Retrospective Real-World US Study. Patient preference and adherence, 69-88. https://doi.org/10.2147/PPA.S437396 PMID: 38223442",
                    "38223442"
                ],
                [
                    "Mark Esguerra, Emily Rubenstein Engel (2024). Fremanezumab-associated injection site alopecia. BMJ case reports. https://doi.org/10.1136/bcr-2024-260741 PMID: 39134332",
                    "39134332"
                ],
                [
                    "E Pons-Fuster, O Lozano-Caballero, S Martín-Balbuena, C Lucas-Ródenas, A Mancebo-González, I De Gorostiza-Frías, C M González-Ponce (2024). Anti‑CGRP monoclonal antibodies in resistant migraine: preliminary real-world effectiveness and clinical predictors of response at two years. International journal of clinical pharmacy, 1317-1326. https://doi.org/10.1007/s11096-024-01758-2 PMID: 38990457",
                    "38990457"
                ],
                [
                    "Elena Cresta, Alessia Bellotti, Giovanni Rinaldi, Ilenia Corbelli, Paola Sarchielli (2024). Effect of anti-CGRP-targeted therapy on migraine aura: Results of an observational case series study. CNS neuroscience & therapeutics, e14595. https://doi.org/10.1111/cns.14595 PMID: 38332541",
                    "38332541"
                ],
                [
                    "Marta Waliszewska-Prosół, Paolo Martelletti (2024). Real-world effectiveness of fremanezumab in patients with migraine switching from another mAb targeting the CGRP pathway. Dental and medical problems, 9-11. https://doi.org/10.17219/dmp/174706 PMID: 38284301",
                    "38284301"
                ],
                [
                    "Davide Mascarella, Giorgia Andrini, Carlo Baraldi, Claudia Altamura, Valentina Favoni, Flavia Lo Castro, Giulia Pierangeli, Fabrizio Vernieri, Simona Guerzoni, Sabina Cevoli (2024). Blood pressure monitoring in elderly migraineurs starting an anti-CGRP monoclonal antibody: a real-world prospective study. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 5365-5373. https://doi.org/10.1007/s10072-024-07567-9 PMID: 38795273",
                    "38795273"
                ],
                [
                    "Frank Porreca, Edita Navratilova, Joe Hirman, Antoinette Maassen van den Brink, Richard B Lipton, David W Dodick (2024). Evaluation of outcomes of calcitonin gene-related peptide (CGRP)-targeting therapies for acute and preventive migraine treatment based on patient sex. Cephalalgia : an international journal of headache, 3331024241238153. https://doi.org/10.1177/03331024241238153 PMID: 38477313",
                    "38477313"
                ],
                [
                    "Bianca Orlando, Gabriella Egeo, Cinzia Aurilia, Giulia Fiorentini, Piero Barbanti (2024). Calcitonin Gene-Related Peptide Monoclonal Antibodies: Key Lessons from Real-World Evidence. Brain sciences. https://doi.org/10.3390/brainsci14090948 PMID: 39335442",
                    "39335442"
                ]
            ]
        ],
        [
            [
                "rimegepant sulfate",
                "CGRP"
            ],
            19.810872,
            [
                [
                    "Patrick Eugeni, Megan E Rooney, Nicolas P Saikali, Zhongzheng Niu, Maurice T Driessen, Lynda J Krasenbaum, Karen Carr, Michael J Seminerio, Jennifer W McVige (2025). US Real-World Effectiveness, Tolerability, and Healthcare Resource Utilization After Addition of Fremanezumab for Preventive Treatment in Patients Using Gepants for Acute Treatment of Migraine: Results From a Retrospective Chart Review. Advances in therapy. https://doi.org/10.1007/s12325-024-03063-w PMID: 39775579",
                    "39775579"
                ],
                [
                    "Luigi Francesco Iannone, Gloria Vaghi, Gabriele Sebastianelli, Francesco Casillo, Antonio Russo, Marcello Silvestro, Francesca Pistoia, Giorgio Dalla Volta, Matteo Cortinovis, Alberto Chiarugi, Danilo Antonio Montisano, Maria Pia Prudenzano, Sabina Cevoli, Edoardo Mampreso, Gianluca Avino, Marina Romozzi, Mariarosaria Valente, Carla Fasano, Stefania Battistini, Antonio Granato, Elisa Maria Piella, Innocenzo Rainero, Raffaele Ornello, Roberto De Icco,   (2025). Effectiveness and tolerability of rimegepant in the acute treatment of migraine: a real-world, prospective, multicentric study (GAINER study). The journal of headache and pain, 4. https://doi.org/10.1186/s10194-024-01935-8 PMID: 39762740",
                    "39762740"
                ],
                [
                    "Samaira Younis, Nina V Latysheva, Alexey B Danilov, Messoud Ashina (2024). CGRP receptor antagonists (gepants). Handbook of clinical neurology, 51-66. https://doi.org/10.1016/B978-0-12-823357-3.00033-1 PMID: 38307667",
                    "38307667"
                ],
                [
                    "Tessa de Vries, Eloísa Rubio-Beltrán, Antoon van den Bogaerdt, Ruben Dammers, A H Jan Danser, Josefin Snellman, Jeanine Bussiere, Antoinette MaassenVanDenBrink (2024). Pharmacology of erenumab in human isolated coronary and meningeal arteries: Additional effect of gepants on top of a maximum effect of erenumab. British journal of pharmacology, 1720-1733. https://doi.org/10.1111/bph.16322 PMID: 38320397",
                    "38320397"
                ],
                [
                    "Yiya Zhang, Tao Li, Han Zhao, Xin Xiao, Ximin Hu, Ben Wang, Yingxue Huang, Zhinan Yin, Yun Zhong, Yangfan Li, Ji Li (2024). High-sensitive sensory neurons exacerbate rosacea-like dermatitis in mice by activating γδ T cells directly. Nature communications, 7265. https://doi.org/10.1038/s41467-024-50970-1 PMID: 39179539",
                    "39179539"
                ],
                [
                    "Frank Porreca, Edita Navratilova, Joe Hirman, Antoinette Maassen van den Brink, Richard B Lipton, David W Dodick (2024). Evaluation of outcomes of calcitonin gene-related peptide (CGRP)-targeting therapies for acute and preventive migraine treatment based on patient sex. Cephalalgia : an international journal of headache, 3331024241238153. https://doi.org/10.1177/03331024241238153 PMID: 38477313",
                    "38477313"
                ],
                [
                    "Lanfranco Pellesi, Paolo Martelletti (2024). Situational prevention in migraine: are we doing the right thing? The journal of headache and pain, 137. https://doi.org/10.1186/s10194-024-01841-z PMID: 39174943",
                    "39174943"
                ],
                [
                    "Robert Croop, Gary Berman, David Kudrow, Kathleen Mullin, Alexandra Thiry, Meghan Lovegren, Gilbert L'Italien, Richard B Lipton (2024). A multicenter, open-label long-term safety study of rimegepant for the acute treatment of migraine. Cephalalgia : an international journal of headache, 3331024241232944. https://doi.org/10.1177/03331024241232944 PMID: 38659334",
                    "38659334"
                ],
                [
                    "Ryan Thaliffdeen, Anthony Yu, Karen Rascati (2024). Cost-Effectiveness Evaluation of Oral CGRP Antagonists, Atogepant and Rimegepant, for the Preventative Treatment of Episodic Migraine: Results from a US Societal Perspective Model. Clinical drug investigation, 209-217. https://doi.org/10.1007/s40261-024-01345-3 PMID: 38381352",
                    "38381352"
                ],
                [
                    "Richard B Lipton (2024). Preventive Treatment of Migraine. Continuum (Minneapolis, Minn.), 364-378. https://doi.org/10.1212/CON.0000000000001418 PMID: 38568488",
                    "38568488"
                ]
            ]
        ],
        [
            [
                "Migraine",
                "rimegepant sulfate"
            ],
            2.226904,
            [
                [
                    "Abimael González-Hernández, Carlos M Villalón (2025). The influence of pharmacodynamics and pharmacokinetics on the antimigraine efficacy and safety of novel anti-CGRPergic pharmacotherapies: a narrative review. Expert opinion on drug metabolism & toxicology, 41-52. https://doi.org/10.1080/17425255.2024.2409253 PMID: 39319681",
                    "39319681"
                ],
                [
                    "Patrick Eugeni, Megan E Rooney, Nicolas P Saikali, Zhongzheng Niu, Maurice T Driessen, Lynda J Krasenbaum, Karen Carr, Michael J Seminerio, Jennifer W McVige (2025). US Real-World Effectiveness, Tolerability, and Healthcare Resource Utilization After Addition of Fremanezumab for Preventive Treatment in Patients Using Gepants for Acute Treatment of Migraine: Results From a Retrospective Chart Review. Advances in therapy. https://doi.org/10.1007/s12325-024-03063-w PMID: 39775579",
                    "39775579"
                ],
                [
                    "A Mínguez-Olaondo, A López-Bravo, S Quintas, C Nieves-Castellanos, A Layos-Romero, R Belvís, P Irimia, S Díaz-Insa (2024). [New therapeutic era for migraine attacks with recently approved monoclonal antibodies, ditans and gepants]. Revista de neurologia, 47-57. https://doi.org/10.33588/rn.7802.2023176 PMID: 38223948",
                    "38223948"
                ],
                [
                    "Cristina Tassorelli, Kateryna Onishchenko, Rashmi B Halker Singh, Molly Duan, Laure Dupont-Benjamin, Matthew Hemstock, Corey Voller, Peter McAllister, Stephanie J Nahas, Pranav Gandhi, Jessica Ailani (2024). Comparative efficacy, quality of life, safety, and tolerability of atogepant and rimegepant in migraine prevention: A matching-adjusted indirect comparison analysis. Cephalalgia : an international journal of headache, 3331024241235156. https://doi.org/10.1177/03331024241235156 PMID: 38410850",
                    "38410850"
                ],
                [
                    "Wattakorn Laohapiboolrattana, Priabprat Jansem, Prakit Anukoolwittaya, Duangnapa Roongpiboonsopit, Akarin Hiransuthikul, Thanakit Pongpitakmetha, Sekh Thanprasertsuk, Wanakorn Rattanawong (2024). Efficacy of lasmiditan, rimegepant and ubrogepant for acute treatment of migraine in triptan insufficient responders: systematic review and network meta-analysis. The journal of headache and pain, 194. https://doi.org/10.1186/s10194-024-01904-1 PMID: 39516789",
                    "39516789"
                ],
                [
                    "Frank Porreca, Edita Navratilova, Joe Hirman, Antoinette Maassen van den Brink, Richard B Lipton, David W Dodick (2024). Evaluation of outcomes of calcitonin gene-related peptide (CGRP)-targeting therapies for acute and preventive migraine treatment based on patient sex. Cephalalgia : an international journal of headache, 3331024241238153. https://doi.org/10.1177/03331024241238153 PMID: 38477313",
                    "38477313"
                ],
                [
                    "Richard B Lipton (2024). Preventive Treatment of Migraine. Continuum (Minneapolis, Minn.), 364-378. https://doi.org/10.1212/CON.0000000000001418 PMID: 38568488",
                    "38568488"
                ],
                [
                    "Hema Mistry, Seyran Naghdi, Anna Brown, Sophie Rees, Jason Madan, Amy Grove, Saval Khanal, Callum Duncan, Manjit Matharu, Andrew Cooklin, Aiva Aksentyte, Natasha Davies, Martin Underwood (2024). Preventive drug treatments for adults with chronic migraine: a systematic review with economic modelling. Health technology assessment (Winchester, England), 1-329. https://doi.org/10.3310/AYWA5297 PMID: 39365169",
                    "39365169"
                ],
                [
                    "Terence Fullerton, Glenn Pixton (2024). Long-Term Use of Rimegepant 75 mg for the Acute Treatment of Migraine is Associated with a Reduction in the Utilization of Select Analgesics and Antiemetics. Journal of pain research, 1751-1760. https://doi.org/10.2147/JPR.S456006 PMID: 38764606",
                    "38764606"
                ],
                [
                    "Deirdre M Boucherie, Ruben Dammers, Arnaud Vincent, A H Jan Danser, Antoinette MaassenVanDenBrink (2024). Comparison of gepant effects at therapeutic plasma concentrations: connecting pharmacodynamics and pharmacokinetics. The journal of headache and pain, 141. https://doi.org/10.1186/s10194-024-01846-8 PMID: 39198753",
                    "39198753"
                ]
            ]
        ],
        [
            [
                "Migraine",
                "CGRP"
            ],
            2.3998795,
            [
                [
                    "Sajjad Jabbari, Zainul Amiruddin Zakaria, Irwin Rose Alencar de Menezes, Saeed Mohammadi (2025). Antinociceptive, antineuropathic, and antimigraine-like activities ofFritillariaimperialis L. rich in verticinone on rats: Mechanisms of action. Journal of ethnopharmacology, 119174. https://doi.org/10.1016/j.jep.2024.119174 PMID: 39613005",
                    "39613005"
                ],
                [
                    "Lauren Powell, Fiona O'Sullivan, Pramoda Jayasinghe, Basia Rogula, Feng Dai, Jessica Cirillo, Samantha Sweeney, Lucy Abraham, Jessica Ailani (2025). Reduction of pain and functional disability over time in patients treated with zavegepant: a post-hoc analysis of the BHV3500-301 phase 3 randomized controlled trial. The journal of headache and pain, 1. https://doi.org/10.1186/s10194-024-01915-y PMID: 39748312",
                    "39748312"
                ],
                [
                    "Davide Para, Chiara Camponovo, Gianna Carla Riccitelli, Giulia Mallucci, Paolo Maino, Camilla Mondini Trissino da Lodi, Demurtas Saudina, Pierpaolo Trimboli, Claudio Gobbi, Chiara Zecca (2024). Assessment of Bone Mineral Density Over 1 Year in a Cross-Sectional Cohort of Migraine Patients Receiving Anti-CGRP Monoclonal Antibodies. CNS drugs, 819-825. https://doi.org/10.1007/s40263-024-01104-0 PMID: 39174745",
                    "39174745"
                ],
                [
                    "Yao Zhang, Fei Ge, Yamin Luo, Xuenian Ji, Zijian Liu, Yuehua Qiu, Jianchen Hou, Ranran Zhou, Caihong Zhao, Qianwei Xu, Shujing Zhang, Xue Yu, Chunguo Wang, Dongyu Ge, Fengxian Meng, Xiaohua Tao (2024). Paeonol and glycyrrhizic acid in combination ameliorate the recurrent nitroglycerin-induced migraine-like phenotype in rats by regulating the GABBR2/TRPM8/PRKACA/TRPV1 pathway. Journal of ethnopharmacology, 118464. https://doi.org/10.1016/j.jep.2024.118464 PMID: 38908492",
                    "38908492"
                ],
                [
                    "E Pons-Fuster, O Lozano-Caballero, S Martín-Balbuena, C Lucas-Ródenas, A Mancebo-González, I De Gorostiza-Frías, C M González-Ponce (2024). Anti‑CGRP monoclonal antibodies in resistant migraine: preliminary real-world effectiveness and clinical predictors of response at two years. International journal of clinical pharmacy, 1317-1326. https://doi.org/10.1007/s11096-024-01758-2 PMID: 38990457",
                    "38990457"
                ],
                [
                    "Richard B Lipton, Stephanie J Nahas, Patricia Pozo-Rosich, Tanya Bilchik, Peter McAllister, Michelle Finnegan, Yingyi Liu, Natty Chalermpalanupap, Brett Dabruzzo, David W Dodick (2024). Sustained response to atogepant in episodic migraine: post hoc analyses of a 12-week randomized trial and a 52-week long-term safety trial. The journal of headache and pain, 83. https://doi.org/10.1186/s10194-024-01783-6 PMID: 38773375",
                    "38773375"
                ],
                [
                    "Lanfranco Pellesi, Dilara Onan, Paolo Martelletti (2024). Onabotulinumtoxin A for the Treatment of Post-Traumatic Headache: Is It Better than Anti-CGRP Antibodies? Toxins. https://doi.org/10.3390/toxins16100427 PMID: 39453203",
                    "39453203"
                ],
                [
                    "Richard B Lipton (2024). Preventive Treatment of Migraine. Continuum (Minneapolis, Minn.), 364-378. https://doi.org/10.1212/CON.0000000000001418 PMID: 38568488",
                    "38568488"
                ],
                [
                    "Katherine Phillips, Benjamin R Wakerley (2024). CGRP therapy in primary care for migraine: prevention and acute medication. The British journal of general practice : the journal of the Royal College of General Practitioners, 521-522. https://doi.org/10.3399/bjgp24X739893 PMID: 39481905",
                    "39481905"
                ],
                [
                    "Nazia Karsan, Lars Edvinsson, Laszlo Vecsei, Peter J Goadsby (2024). Pituitary cyclase-activating polypeptide targeted treatments for the treatment of primary headache disorders. Annals of clinical and translational neurology, 1654-1668. https://doi.org/10.1002/acn3.52119 PMID: 38887982",
                    "38887982"
                ]
            ]
        ],
        [
            [
                "CGRP",
                "Calcitonin"
            ],
            10.331228,
            [
                [
                    "Aida Maddahi, Jacob C A Edvinsson, Lars Edvinsson (2024). Sex differences in expression of CGRP family of receptors and ligands in the rat trigeminal system. The journal of headache and pain, 193. https://doi.org/10.1186/s10194-024-01893-1 PMID: 39516766",
                    "39516766"
                ],
                [
                    "Javier Caviedes-Bucheli, Hernan Dario Muñoz-Alvear, Luis Fernando Lopez-Moncayo, Kranthi Raja Kacharaju, Adriana Carolina Velasquez-Rivera, Luis Alberto Carlosama-Recalde, Juan Camilo Pazmiño, Jose Francisco Gomez-Sosa, Luis Eduardo Diaz-Barrera, Hugo Roberto Munoz (2024). Substance P/calcitonin gene-related peptide and their receptors expression in human periodontal ligament after root canal preparation with five different systems. International endodontic journal, 576-585. https://doi.org/10.1111/iej.14035 PMID: 38294105",
                    "38294105"
                ],
                [
                    "Marta Pascual-Mato, Gabriel Gárate, Vicente González-Quintanilla, Jorge Madera-Fernández, Beatriz Castro, María José García, Javier Crespo, Montserrat Rivero, Julio Pascual (2024). Differences in circulating alpha-calcitonin gene-related peptide levels in inflammatory bowel disease and its relation to migraine comorbidity: A cross-sectional study. Headache, 849-858. https://doi.org/10.1111/head.14768 PMID: 38922858",
                    "38922858"
                ],
                [
                    "Ja Bin Hong, Kristin Sophie Lange, Lucas Hendrik Overeem, Paul Triller, Bianca Raffaelli, Uwe Reuter (2023). A Scoping Review and Meta-Analysis of Anti-CGRP Monoclonal Antibodies: Predicting Response. Pharmaceuticals (Basel, Switzerland). https://doi.org/10.3390/ph16070934 PMID: 37513846",
                    "37513846"
                ],
                [
                    "Zhi Yang, Hongchun Li, Pengfei Wu, Qingyan Li, ChunYan Yu, Denian Wang, Weimin Li (2023). Multi-biological functions of intermedin in diseases. Frontiers in physiology, 1233073. https://doi.org/10.3389/fphys.2023.1233073 PMID: 37745233",
                    "37745233"
                ],
                [
                    "Lavinia Boccia, Tito Borner, Misgana Y Ghidewon, Patricia Kulka, Chiara Piffaretti, Sarah A Doebley, Bart C De Jonghe, Harvey J Grill, Thomas A Lutz, Christelle Le Foll (2022). Hypophagia induced by salmon calcitonin, but not by amylin, is partially driven by malaise and is mediated by CGRP neurons. Molecular metabolism, 101444. https://doi.org/10.1016/j.molmet.2022.101444 PMID: 35091058",
                    "35091058"
                ],
                [
                    "Yanhong Wang, Jihua Tian, Yang Mi, Xiaojun Ren, Shizhong Lian, Jing Kang, Juanjuan Wang, Haojing Zang, Zhijing Wu, Jia Yang, Xi Qiao, Xiaoshuang Zhou, Guiqin Wang, Yun Zhou, Rongshan Li (2021). Experimental study on renoprotective effect of intermedin on diabetic nephropathy. Molecular and cellular endocrinology, 111224. https://doi.org/10.1016/j.mce.2021.111224 PMID: 33675865",
                    "33675865"
                ],
                [
                    "Alejandro Labastida-Ramírez, Eloísa Rubio-Beltrán, Kristian A Haanes, Kayi Y Chan, Ingrid M Garrelds, Kirk W Johnson, Alexander H J Danser, Carlos M Villalón, Antoinette MaassenVanDenBrink (2020). Lasmiditan inhibits calcitonin gene-related peptide release in the rodent trigeminovascular system. Pain, 1092-1099. https://doi.org/10.1097/j.pain.0000000000001801 PMID: 31977930",
                    "31977930"
                ],
                [
                    "Fan Bu, Mingming Yuan, Dongqing Ma, Ying Zhu, Minyan Wang (2020). Inhibition of NR2A reduces calcitonin gene-related peptide gene expression induced by cortical spreading depression in rat amygdala. Neuropeptides, 102097. https://doi.org/10.1016/j.npep.2020.102097 PMID: 33059243",
                    "33059243"
                ],
                [
                    "Patrizia Ferroni, Piero Barbanti, Antonella Spila, Federica Fratangeli, Cinzia Aurilia, Luisa Fofi, Gabriella Egeo, Fiorella Guadagni (2019). Circulating Biomarkers in Migraine: New Opportunities for Precision Medicine. Current medicinal chemistry, 6191-6206. https://doi.org/10.2174/0929867325666180622122938 PMID: 29932027",
                    "29932027"
                ]
            ]
        ],
        [
            [
                "Migraine",
                "Topiramate"
            ],
            3.8342003,
            [
                [
                    "Artemis Mavridi, Aine Redmond, Paraschos Archontakis-Barakakis, Petya Bogdanova-Mihaylova, Christina I Deligianni, Dimos D Mitsikostas, Theodoros Mavridis (2024). Onabotulinumtoxina in the Prevention of Migraine in Pediatric Population: A Systematic Review. Toxins. https://doi.org/10.3390/toxins16070295 PMID: 39057935",
                    "39057935"
                ],
                [
                    "Hema Mistry, Seyran Naghdi, Anna Brown, Sophie Rees, Jason Madan, Amy Grove, Saval Khanal, Callum Duncan, Manjit Matharu, Andrew Cooklin, Aiva Aksentyte, Natasha Davies, Martin Underwood (2024). Preventive drug treatments for adults with chronic migraine: a systematic review with economic modelling. Health technology assessment (Winchester, England), 1-329. https://doi.org/10.3310/AYWA5297 PMID: 39365169",
                    "39365169"
                ],
                [
                    "Yuhling Wang, Shaoyu Yen, Yen-Yu Ian Shih, Chien-Wen Lai, Yu-Lin Chen, Li-Tzong Chen, Hsi Chen, Lun-De Liao (2024). Topiramate suppresses peri-infarct spreading depolarization and improves outcomes in a rat model of photothrombotic stroke. iScience, 110033. https://doi.org/10.1016/j.isci.2024.110033 PMID: 38947531",
                    "38947531"
                ],
                [
                    "Seyran Naghdi, Martin Underwood, Anna Brown, Manjit Matharu, Callum Duncan, Natasha Davies, Aiva Aksentyte, Hema Mistry (2024). Adverse and serious adverse events incidence of pharmacological interventions for managing chronic and episodic migraine in adults: a systematic review. BMJ neurology open, e000616. https://doi.org/10.1136/bmjno-2023-000616 PMID: 38646505",
                    "38646505"
                ],
                [
                    "Christian Lampl, Antoinette MaassenVanDenBrink, Christina I Deligianni, Raquel Gil-Gouveia, Tanvir Jassal, Margarita Sanchez-Del-Rio, Uwe Reuter, Derya Uluduz, Jan Versijpt, Dena Zeraatkar, Simona Sacco (2023). The comparative effectiveness of migraine preventive drugs: a systematic review and network meta-analysis. The journal of headache and pain, 56. https://doi.org/10.1186/s10194-023-01594-1 PMID: 37208596",
                    "37208596"
                ],
                [
                    "Leon S Moskatel, Anna Graber-Naidich, Zihuai He, Niushen Zhang (2023). The introduction of the CGRP monoclonal antibodies and their effect on the prescription patterns of chronic migraine preventive medications in a tertiary headache center: A retrospective, observational analysis. Headache. https://doi.org/10.1111/head.14642 PMID: 37882379",
                    "37882379"
                ],
                [
                    "Ramesh Boinpally, Danielle McGeeney, Lisa Borbridge, Joel Trugman (2023). Pharmacokinetics and Safety of Coadministered Atogepant and Topiramate in Healthy Participants: A Phase 1, Open-Label, Drug-Drug Interaction Study. Clinical pharmacology in drug development, 1013-1021. https://doi.org/10.1002/cpdd.1267 PMID: 37210713",
                    "37210713"
                ],
                [
                    "Prateek Kumar Panda, Aparna Ramachandran, Indar Kumar Sharawat (2023). Vitamin D3 Supplementation Along With Topiramate in Pediatric Migraine Prophylaxis: Is it Effective? Journal of child neurology, 103-104. https://doi.org/10.1177/08830738231155792 PMID: 36760132",
                    "36760132"
                ],
                [
                    "Eleonora Rollo, Marina Romozzi, Catello Vollono, Paolo Calabresi, Pierangelo Geppetti, Luigi F Iannone (2023). Antiseizure Medications for the Prophylaxis of Migraine during the Anti- CGRP Drugs Era. Current neuropharmacology, 1767-1785. https://doi.org/10.2174/1570159X21666221228095256 PMID: 36582062",
                    "36582062"
                ],
                [
                    "Maria Tiziana Corasaniti, Giacinto Bagetta, Pierluigi Nicotera, Assunta Tarsitano, Paolo Tonin, Giorgio Sandrini, Gary W Lawrence, Damiana Scuteri (2023). Safety of Onabotulinumtoxin A in Chronic Migraine: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. Toxins. https://doi.org/10.3390/toxins15050332 PMID: 37235366",
                    "37235366"
                ]
            ]
        ],
        [
            [
                "CGRP",
                "Pituitary Adenylate Cyclase-Activating Polypeptide"
            ],
            12.132783,
            [
                [
                    "Xiaoke Li, Kaiqi Chen, Ruonan Liu, Zhaodi Zheng, Xitan Hou (2024). Antimicrobial neuropeptides and their therapeutic potential in vertebrate brain infectious disease. Frontiers in immunology, 1496147. https://doi.org/10.3389/fimmu.2024.1496147 PMID: 39620214",
                    "39620214"
                ],
                [
                    "Joshua L Kamins, Ramin Karimi, Ann Hoffman, Mayumi L Prins, Christopher C Giza (2024). Biomarkers and Endophenotypes of Post-traumatic Headaches. Current pain and headache reports, 1185-1193. https://doi.org/10.1007/s11916-024-01255-1 PMID: 39136870",
                    "39136870"
                ],
                [
                    "Lanfranco Pellesi, Messoud Ashina, Paolo Martelletti (2024). Targeting the PACAP-38 pathway is an emerging therapeutic strategy for migraine prevention. Expert opinion on emerging drugs, 57-64. https://doi.org/10.1080/14728214.2024.2317778 PMID: 38337150",
                    "38337150"
                ],
                [
                    "Lanfranco Pellesi, Dilara Onan, Paolo Martelletti (2024). Onabotulinumtoxin A for the Treatment of Post-Traumatic Headache: Is It Better than Anti-CGRP Antibodies? Toxins. https://doi.org/10.3390/toxins16100427 PMID: 39453203",
                    "39453203"
                ],
                [
                    "Song Guo, Sarah Louise Christensen, Mohammad Al-Mahdi Al-Karagholi, Jes Olesen (2024). Molecular nociceptive mechanisms in migraine: The migraine cascade. European journal of neurology, e16333. https://doi.org/10.1111/ene.16333 PMID: 38894592",
                    "38894592"
                ],
                [
                    "Songyi Park, Harry Jung, Sang-Won Han, Sang-Hwa Lee, Jong-Hee Sohn (2024). Differences in Neuropathology between Nitroglycerin-Induced Mouse Models of Episodic and Chronic Migraine. International journal of molecular sciences. https://doi.org/10.3390/ijms25073706 PMID: 38612517",
                    "38612517"
                ],
                [
                    "Nazia Karsan, Lars Edvinsson, Laszlo Vecsei, Peter J Goadsby (2024). Pituitary cyclase-activating polypeptide targeted treatments for the treatment of primary headache disorders. Annals of clinical and translational neurology, 1654-1668. https://doi.org/10.1002/acn3.52119 PMID: 38887982",
                    "38887982"
                ],
                [
                    "Rosaria Greco, Miriam Francavilla, Sara Facchetti, Chiara Demartini, Anna Maria Zanaboni, Maria Irene Antonangeli, Mariano Maffei, Franca Cattani, Andrea Aramini, Marcello Allegretti, Cristina Tassorelli, Lidia De Filippis (2024). Intranasal administration of recombinant human BDNF as a potential therapy for some primary headaches. The journal of headache and pain, 184. https://doi.org/10.1186/s10194-024-01890-4 PMID: 39455939",
                    "39455939"
                ],
                [
                    "Tamás Körtési, Gábor Nagy-Grócz, László Vécsei (2024). The role of kynurenines in migraine-related neuroimmune pathways. The journal of headache and pain, 129. https://doi.org/10.1186/s10194-024-01833-z PMID: 39107712",
                    "39107712"
                ],
                [
                    "S Pérez-Pereda, M Toriello, C Bailón, O Umaran Alfageme, F Hoyuela, V González-Quintanilla, A Oterino (2023). Frequency and impact of post-traumatic stress disorder and traumatic life events in patients with migraine. Neurologia, S13-S21. https://doi.org/10.1016/j.nrleng.2021.07.008 PMID: 39528016",
                    "39528016"
                ]
            ]
        ],
        [
            [
                "Migraine",
                "Botulinum Toxins, Type A"
            ],
            2.8261864,
            [
                [
                    "Agustin Melo-Carrillo, Andrew M Strassman, Khrystoffer-Kihan J Malcolm, Aubrey Manack Adams, Brett Dabruzzo, Ron S Briode, Mitchell F Brin, Rami Burstein (2024). Exploring the effects of extracranial injections of botulinum toxin type A on activation and sensitization of central trigeminovascular neurons by cortical spreading depression in male and female rats. Cephalalgia : an international journal of headache, 3331024241278919. https://doi.org/10.1177/03331024241278919 PMID: 39252510",
                    "39252510"
                ],
                [
                    "Lanfranco Pellesi, Dilara Onan, Paolo Martelletti (2024). Onabotulinumtoxin A for the Treatment of Post-Traumatic Headache: Is It Better than Anti-CGRP Antibodies? Toxins. https://doi.org/10.3390/toxins16100427 PMID: 39453203",
                    "39453203"
                ],
                [
                    "Dilara Onan, Fatemeh Farham, Paolo Martelletti (2024). Clinical Conditions Targeted by OnabotulinumtoxinA in Different Ways in Medicine. Toxins. https://doi.org/10.3390/toxins16070309 PMID: 39057949",
                    "39057949"
                ],
                [
                    "Grace Forde, Benjamin M Brucker, Kimberly Becker Ifantides, Atul T Patel, Angeli Mayadev, Theodore Brown, Ziyad Ayyoub, Kenneth Martinez, Ritu Singh, Mariana Nelson, Simona Battucci, Irina Yushmanova, Ahunna Ukah, Christopher Rhyne (2024). SYNCHRONIZE: Real-World Retrospective Safety Analysis of Patients Treated with OnabotulinumtoxinA for More than One Therapeutic Indication. Toxins. https://doi.org/10.3390/toxins16100420 PMID: 39453196",
                    "39453196"
                ],
                [
                    "Artemis Mavridi, Aine Redmond, Paraschos Archontakis-Barakakis, Petya Bogdanova-Mihaylova, Christina I Deligianni, Dimos D Mitsikostas, Theodoros Mavridis (2024). Onabotulinumtoxina in the Prevention of Migraine in Pediatric Population: A Systematic Review. Toxins. https://doi.org/10.3390/toxins16070295 PMID: 39057935",
                    "39057935"
                ],
                [
                    "Matthew Robbins (2024). New Daily Persistent Headache. Continuum (Minneapolis, Minn.), 425-437. https://doi.org/10.1212/CON.0000000000001398 PMID: 38568492",
                    "38568492"
                ],
                [
                    "Hema Mistry, Seyran Naghdi, Anna Brown, Sophie Rees, Jason Madan, Amy Grove, Saval Khanal, Callum Duncan, Manjit Matharu, Andrew Cooklin, Aiva Aksentyte, Natasha Davies, Martin Underwood (2024). Preventive drug treatments for adults with chronic migraine: a systematic review with economic modelling. Health technology assessment (Winchester, England), 1-329. https://doi.org/10.3310/AYWA5297 PMID: 39365169",
                    "39365169"
                ],
                [
                    "Seyran Naghdi, Martin Underwood, Anna Brown, Manjit Matharu, Callum Duncan, Natasha Davies, Aiva Aksentyte, Hema Mistry (2024). Adverse and serious adverse events incidence of pharmacological interventions for managing chronic and episodic migraine in adults: a systematic review. BMJ neurology open, e000616. https://doi.org/10.1136/bmjno-2023-000616 PMID: 38646505",
                    "38646505"
                ],
                [
                    "Richard N Miller, Monica E Kim, Muhammed Talha Gunduz, Shawn C Aylward (2024). Advancements in pediatric headache. Current opinion in pediatrics, 624-629. https://doi.org/10.1097/MOP.0000000000001412 PMID: 39400079",
                    "39400079"
                ],
                [
                    "Shih-Pin Chen (2023). Migraine and treatment-resistant depression. Progress in brain research, 149-173. https://doi.org/10.1016/bs.pbr.2023.05.001 PMID: 37806714",
                    "37806714"
                ]
            ]
        ],
        [
            [
                "CGRP",
                "Calcitonin Gene-Related Peptide"
            ],
            79.53516400000001,
            [
                [
                    "Lauren Powell, Fiona O'Sullivan, Pramoda Jayasinghe, Basia Rogula, Feng Dai, Jessica Cirillo, Samantha Sweeney, Lucy Abraham, Jessica Ailani (2025). Reduction of pain and functional disability over time in patients treated with zavegepant: a post-hoc analysis of the BHV3500-301 phase 3 randomized controlled trial. The journal of headache and pain, 1. https://doi.org/10.1186/s10194-024-01915-y PMID: 39748312",
                    "39748312"
                ],
                [
                    "Davide Para, Chiara Camponovo, Gianna Carla Riccitelli, Giulia Mallucci, Paolo Maino, Camilla Mondini Trissino da Lodi, Demurtas Saudina, Pierpaolo Trimboli, Claudio Gobbi, Chiara Zecca (2024). Assessment of Bone Mineral Density Over 1 Year in a Cross-Sectional Cohort of Migraine Patients Receiving Anti-CGRP Monoclonal Antibodies. CNS drugs, 819-825. https://doi.org/10.1007/s40263-024-01104-0 PMID: 39174745",
                    "39174745"
                ],
                [
                    "Lanfranco Pellesi, Dilara Onan, Paolo Martelletti (2024). Onabotulinumtoxin A for the Treatment of Post-Traumatic Headache: Is It Better than Anti-CGRP Antibodies? Toxins. https://doi.org/10.3390/toxins16100427 PMID: 39453203",
                    "39453203"
                ],
                [
                    "Richard B Lipton (2024). Preventive Treatment of Migraine. Continuum (Minneapolis, Minn.), 364-378. https://doi.org/10.1212/CON.0000000000001418 PMID: 38568488",
                    "38568488"
                ],
                [
                    "Adam B Willits, Leena Kader, Olivia Eller, Emily Roberts, Bailey Bye, Taylor Strope, Bret D Freudenthal, Shahid Umar, Sree Chintapalli, Kartik Shankar, Dong Pei, Julie Christianson, Kyle M Baumbauer, Erin E Young (2024). Spinal cord injury-induced neurogenic bowel: A role for host-microbiome interactions in bowel pain and dysfunction. Neurobiology of pain (Cambridge, Mass.), 100156. https://doi.org/10.1016/j.ynpai.2024.100156 PMID: 38601267",
                    "38601267"
                ],
                [
                    "Grazia Dell Agnello, Carlotta Buzzoni, Amalia Antenori, Federico Torelli, Claudia Altamura, Fabrizio Vernieri (2023). Galcanezumab in the Treatment of Migraine: A Narrative Review of Real-World Studies. Clinical neuropharmacology, 220-228. https://doi.org/10.1097/WNF.0000000000000571 PMID: 37962309",
                    "37962309"
                ],
                [
                    "Christian Lampl, Antoinette MaassenVanDenBrink, Christina I Deligianni, Raquel Gil-Gouveia, Tanvir Jassal, Margarita Sanchez-Del-Rio, Uwe Reuter, Derya Uluduz, Jan Versijpt, Dena Zeraatkar, Simona Sacco (2023). The comparative effectiveness of migraine preventive drugs: a systematic review and network meta-analysis. The journal of headache and pain, 56. https://doi.org/10.1186/s10194-023-01594-1 PMID: 37208596",
                    "37208596"
                ],
                [
                    "Alicia Gonzalez-Martinez, Ancor Sanz-García, David García-Azorín, Jaime Samuel Rodriguez-Vico, Alex Jaimes, Andrea Gómez García, Javier Casas Limón, Javier Díaz de Terán, María Sastre-Real, Javier Membrilla, Germán Latorre, Carlos Calle de Miguel, Sendoa Gil Luque, Cristina Trevino-Peinado, Sonia Quintas, Patricia Heredia, Ana Echavarría Íñiguez, Ángel Guerrero-Peral, Álvaro Sierra, Nuria González-García, Jesús Porta-Etessam, Ana Beatriz Gago-Veiga (2023). Effectiveness, tolerability and response predictors of preventive anti-CGRP mAbs for migraine in patients over 65 years old: a multicenter real-world case-control study. Pain medicine (Malden, Mass.). https://doi.org/10.1093/pm/pnad141 PMID: 37847661",
                    "37847661"
                ],
                [
                    "Daisuke Watabe, Mitsutoshi Tominaga, Sumika Toyama, Kenji Takamori, Hajime Nakano, Hiroo Amano (2023). A severe case of primary erythromelalgia presenting as small fiber neuropathy with a novel SCN9A mutation. The Journal of dermatology, 938-941. https://doi.org/10.1111/1346-8138.16754 PMID: 36815391",
                    "36815391"
                ],
                [
                    "Changqing Mei, Chen Pan, Linbin Xu, Mengmeng Miao, Qichen Lu, Yang Yu, Pengyu Lin, Wenwei Wu, Feng Ni, Yinping Gao, Yuhao Xu, Jia Xu, Xiaowei Chen (2023). Trimethoxyflavanone relieves Paclitaxel-induced neuropathic pain via inhibiting expression and activation of P2X7 and production of CGRP in mice. Neuropharmacology, 109584. https://doi.org/10.1016/j.neuropharm.2023.109584 PMID: 37225085",
                    "37225085"
                ]
            ]
        ],
        [
            [
                "CGRP",
                "Substance P"
            ],
            23.898612999999997,
            [
                [
                    "Javier Caviedes-Bucheli, Hernan Dario Muñoz-Alvear, Luis Fernando Lopez-Moncayo, Kranthi Raja Kacharaju, Adriana Carolina Velasquez-Rivera, Luis Alberto Carlosama-Recalde, Juan Camilo Pazmiño, Jose Francisco Gomez-Sosa, Luis Eduardo Diaz-Barrera, Hugo Roberto Munoz (2024). Substance P/calcitonin gene-related peptide and their receptors expression in human periodontal ligament after root canal preparation with five different systems. International endodontic journal, 576-585. https://doi.org/10.1111/iej.14035 PMID: 38294105",
                    "38294105"
                ],
                [
                    "Mervan Bekdas, Bilgi Saygi, Yasemin Baranoglu Kilinc, Erkan Kilinc (2024). Plasma levels of neurogenic inflammation related neuropeptides in pediatric patients with community-acquired pneumonia and their potential diagnostic value in distinguishing viral and bacterial pneumonia. European journal of pediatrics, 1619-1627. https://doi.org/10.1007/s00431-023-05417-y PMID: 38183438",
                    "38183438"
                ],
                [
                    "Fatemeh Farham, Dilara Onan, Paolo Martelletti (2024). Non-Migraine Head Pain and Botulinum Toxin. Toxins. https://doi.org/10.3390/toxins16100431 PMID: 39453207",
                    "39453207"
                ],
                [
                    "Elin Uzunel, Ann-Charlotte Grahn Kronhed, Christina Kaijser Alin, Aisha Siddiqah Ahmed, Per Wändell, Helena Salminen (2023). The Effect of Group Training or Spinal Orthosis on Quality of Life and Potential Plasma Markers of Pain in Older Women With Osteoporosis. A Randomized Controlled Trial. Archives of rehabilitation research and clinical translation, 100297. https://doi.org/10.1016/j.arrct.2023.100297 PMID: 38163036",
                    "38163036"
                ],
                [
                    "Dulan A Gunawardena, Edward Stanley, Andrea C Issler-Fisher (2023). Understanding Neural Factors in Burn-related Pruritus and Neuropathic Pain. Journal of burn care & research : official publication of the American Burn Association, 1182-1188. https://doi.org/10.1093/jbcr/irad021 PMID: 36794899",
                    "36794899"
                ],
                [
                    "Daisuke Watabe, Mitsutoshi Tominaga, Sumika Toyama, Kenji Takamori, Hajime Nakano, Hiroo Amano (2023). A severe case of primary erythromelalgia presenting as small fiber neuropathy with a novel SCN9A mutation. The Journal of dermatology, 938-941. https://doi.org/10.1111/1346-8138.16754 PMID: 36815391",
                    "36815391"
                ],
                [
                    "Freshet Assefa (2023). The role of sensory and sympathetic nerves in craniofacial bone regeneration. Neuropeptides, 102328. https://doi.org/10.1016/j.npep.2023.102328 PMID: 36827755",
                    "36827755"
                ],
                [
                    "Xiaoxu Zeng, Jia Mai, Hongjian Xie, Ling Yang, Xiaojuan Liu (2023). Activation of CB1R alleviates central sensitization by regulating HCN2-pNR2B signaling in a chronic migraine rat model. The journal of headache and pain, 44. https://doi.org/10.1186/s10194-023-01580-7 PMID: 37085778",
                    "37085778"
                ],
                [
                    "Amnon A Berger, Ariel Winnick, Austin H Carroll, Alexandra Welschmeyer, Nathan Li, Marc Colon, Antonella Paladini, Giovanni F Ramírez, Jamal Hasoon, Elyse M Cornett, Jaehong Song, Giustino Varrassi, Adam M Kaye, Alan D Kaye, Latha Ganti (2022). Rimegepant for the treatment of migraine. Health psychology research, 38534. https://doi.org/10.52965/001c.38534 PMID: 36262478",
                    "36262478"
                ],
                [
                    "Kun-Wu Yang, Pu-Wei Yuan, Bo Dong, Jing-Jie Fan, Ying-Ying Wang, Hui Liu, Xin Chai, Jie Zheng (2020). [Effects of electroacupuncture on pain behavior and pain-related factors in spinal cord dorsal horn and dorsal root ganglia of rats with knee osteoarthritis]. Zhen ci yan jiu = Acupuncture research, 818-22. https://doi.org/10.13702/j.1000-0607.200540 PMID: 33788448",
                    "33788448"
                ]
            ]
        ],
        [
            [
                "Migraine",
                "erenumab"
            ],
            3.2160932,
            [
                [
                    "Anna Maria Florescu, Lærke Vig Lannov, Samaira Younis, Christopher Kjaer Cullum, Basit Ali Chaudhry, Thien Phu Do, Faisal Mohammad Amin (2024). No wearing-off effect of erenumab or fremanezumab for chronic migraine prevention: a single-center, real-world, observational study. Cephalalgia : an international journal of headache, 3331024231222915. https://doi.org/10.1177/03331024231222915 PMID: 38215232",
                    "38215232"
                ],
                [
                    "Oralee J Varnado, Brenna L Brady, Anthony J Zagar, Yvonne P Robles, Margaret Hoyt (2024). Comparison of Treatment Patterns in Patients with Migraine Initiating Calcitonin Gene-Related Peptide Monoclonal Antibodies: A Retrospective Real-World US Study. Patient preference and adherence, 69-88. https://doi.org/10.2147/PPA.S437396 PMID: 38223442",
                    "38223442"
                ],
                [
                    "E Pons-Fuster, O Lozano-Caballero, S Martín-Balbuena, C Lucas-Ródenas, A Mancebo-González, I De Gorostiza-Frías, C M González-Ponce (2024). Anti‑CGRP monoclonal antibodies in resistant migraine: preliminary real-world effectiveness and clinical predictors of response at two years. International journal of clinical pharmacy, 1317-1326. https://doi.org/10.1007/s11096-024-01758-2 PMID: 38990457",
                    "38990457"
                ],
                [
                    "Bianca Orlando, Gabriella Egeo, Cinzia Aurilia, Giulia Fiorentini, Piero Barbanti (2024). Calcitonin Gene-Related Peptide Monoclonal Antibodies: Key Lessons from Real-World Evidence. Brain sciences. https://doi.org/10.3390/brainsci14090948 PMID: 39335442",
                    "39335442"
                ],
                [
                    "Frank Porreca, Edita Navratilova, Joe Hirman, Antoinette Maassen van den Brink, Richard B Lipton, David W Dodick (2024). Evaluation of outcomes of calcitonin gene-related peptide (CGRP)-targeting therapies for acute and preventive migraine treatment based on patient sex. Cephalalgia : an international journal of headache, 3331024241238153. https://doi.org/10.1177/03331024241238153 PMID: 38477313",
                    "38477313"
                ],
                [
                    "Richard B Lipton (2024). Preventive Treatment of Migraine. Continuum (Minneapolis, Minn.), 364-378. https://doi.org/10.1212/CON.0000000000001418 PMID: 38568488",
                    "38568488"
                ],
                [
                    "Hema Mistry, Seyran Naghdi, Anna Brown, Sophie Rees, Jason Madan, Amy Grove, Saval Khanal, Callum Duncan, Manjit Matharu, Andrew Cooklin, Aiva Aksentyte, Natasha Davies, Martin Underwood (2024). Preventive drug treatments for adults with chronic migraine: a systematic review with economic modelling. Health technology assessment (Winchester, England), 1-329. https://doi.org/10.3310/AYWA5297 PMID: 39365169",
                    "39365169"
                ],
                [
                    "Maria Albanese, Francesca Pescini, Chiara Di Bonaventura, Luigi Francesco Iannone, Silvia Bianchi, Anna Poggesi, Mario Bengala, Nicola Biagio Mercuri, Francesco De Cesaris (2024). Long-Term Treatment with the Calcitonin Gene-Related Peptide Receptor Antagonist Erenumab in CADASIL: Two Case Reports. Journal of clinical medicine. https://doi.org/10.3390/jcm13071870 PMID: 38610637",
                    "38610637"
                ],
                [
                    "Robert Urman, Nicole Princic, Fiston Vuvu, Leah B Patel, Sam Oh, David Chandler, Nada Hindiyeh, Mark E Bensink (2024). Changes in Use of Migraine Medications, Healthcare Resource Utilization, and Associated Direct Costs Over 12 Months Following Initiation of Erenumab: A US Retrospective Real-World Analysis. Pain and therapy, 1299-1313. https://doi.org/10.1007/s40122-024-00644-z PMID: 39177937",
                    "39177937"
                ],
                [
                    "Carlos Lazaro-Hernandez, Edoardo Caronna, Joana Rosell-Mirmi, Victor J Gallardo, Alicia Alpuente, Marta Torres-Ferrus, Patricia Pozo-Rosich (2024). Early and annual projected savings from anti-CGRP monoclonal antibodies in migraine prevention: a cost-benefit analysis in the working-age population. The journal of headache and pain, 21. https://doi.org/10.1186/s10194-024-01727-0 PMID: 38347485",
                    "38347485"
                ]
            ]
        ],
        [
            [
                "Migraine",
                "Sumatriptan"
            ],
            3.6761839999999997,
            [
                [
                    "Woo-Seok Ha, JaeWook Jeong, Seungwon Song, Jungyon Yum, Min Kyung Chu (2024). Trends in Triptan Usage in Korea: A Population-Based Cohort Study. Journal of Korean medical science, e222. https://doi.org/10.3346/jkms.2024.39.e222 PMID: 39137809",
                    "39137809"
                ],
                [
                    "Yuxing Liu, Dawei Wu (2023). Bi-directional nasal drug delivery systems: A scoping review of nasal particle deposition patterns and clinical application. Laryngoscope investigative otolaryngology, 1484-1499. https://doi.org/10.1002/lio2.1190 PMID: 38130248",
                    "38130248"
                ],
                [
                    "János Tajti, Anett Csáti, Délia Szok (2023). [Sumatriptan-naproxen sodium fix-dose combination for acute migraine treatment, a review]. Ideggyogyaszati szemle, 293-296. https://doi.org/10.18071/isz.76.0293 PMID: 37782065",
                    "37782065"
                ],
                [
                    "Toru Yamamoto, Yatendra Mulpuri, Mikhail Izraylev, Qianyi Li, Menooa Simonian, Christian Kramme, Brian L Schmidt, Herbert H Seltzman, Igor Spigelman (2021). Selective targeting of peripheral cannabinoid receptors prevents behavioral symptoms and sensitization of trigeminal neurons in mouse models of migraine and medication overuse headache. Pain, 2246-2262. https://doi.org/10.1097/j.pain.0000000000002214 PMID: 33534356",
                    "33534356"
                ],
                [
                    "Alejandro Labastida-Ramírez, Eloísa Rubio-Beltrán, Kristian A Haanes, Kayi Y Chan, Ingrid M Garrelds, Kirk W Johnson, Alexander H J Danser, Carlos M Villalón, Antoinette MaassenVanDenBrink (2020). Lasmiditan inhibits calcitonin gene-related peptide release in the rodent trigeminovascular system. Pain, 1092-1099. https://doi.org/10.1097/j.pain.0000000000001801 PMID: 31977930",
                    "31977930"
                ],
                [
                    "Radhouane Dallel, Amélie Descheemaeker, Philippe Luccarini (2018). Recurrent administration of the nitric oxide donor, isosorbide dinitrate, induces a persistent cephalic cutaneous hypersensitivity: A model for migraine progression. Cephalalgia : an international journal of headache, 776-785. https://doi.org/10.1177/0333102417714032 PMID: 28565942",
                    "28565942"
                ],
                [
                    "Kevin Spielmann, Angela Kayser, Evelin Beck, Reinhard Meister, Christof Schaefer (2018). Pregnancy outcome after anti-migraine triptan use: A prospective observational cohort study. Cephalalgia : an international journal of headache, 1081-1092. https://doi.org/10.1177/0333102417724152 PMID: 28758416",
                    "28758416"
                ],
                [
                    "Piero Barbanti, C Aurilia, G Egeo, L Fofi, R Palmirotta (2017). Serotonin receptor targeted therapy for migraine treatment: an overview of drugs in phase I and II clinical development. Expert opinion on investigational drugs, 269-277. https://doi.org/10.1080/13543784.2017.1283404 PMID: 28103158",
                    "28103158"
                ],
                [
                    "Matilde Capi, Martina Curto, Luana Lionetto, Fernando de Andrés, Giovanna Gentile, Andrea Negro, Paolo Martelletti (2016). Eletriptan in the management of acute migraine: an update on the evidence for efficacy, safety, and consistent response. Therapeutic advances in neurological disorders, 414-23. https://doi.org/10.1177/1756285616650619 PMID: 27582896",
                    "27582896"
                ],
                [
                    "Dongyue Huang, Lynn Ren, Chang-Shen Qiu, Ping Liu, Jonathan Peterson, Yuchio Yanagawa, Yu-Qing Cao (2016). Characterization of a mouse model of headache. Pain, 1744-1760. https://doi.org/10.1097/j.pain.0000000000000578 PMID: 27058678",
                    "27058678"
                ]
            ]
        ]
    ]
}